nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—Dysaesthesia—Capecitabine—esophageal cancer	0.0117	0.0248	CcSEcCtD
Rotigotine—Prurigo—Capecitabine—esophageal cancer	0.0109	0.0232	CcSEcCtD
Rotigotine—Haematocrit decreased—Methotrexate—esophageal cancer	0.0101	0.0214	CcSEcCtD
Rotigotine—Balance disorder—Capecitabine—esophageal cancer	0.00924	0.0196	CcSEcCtD
Rotigotine—Infection—Carboplatin—esophageal cancer	0.00828	0.0176	CcSEcCtD
Rotigotine—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00749	0.0159	CcSEcCtD
Rotigotine—Laryngeal pain—Capecitabine—esophageal cancer	0.00741	0.0157	CcSEcCtD
Rotigotine—Haemoglobin decreased—Capecitabine—esophageal cancer	0.00734	0.0156	CcSEcCtD
Rotigotine—Pain—Carboplatin—esophageal cancer	0.00713	0.0151	CcSEcCtD
Rotigotine—Tongue disorder—Capecitabine—esophageal cancer	0.00695	0.0148	CcSEcCtD
Rotigotine—Hiccups—Cisplatin—esophageal cancer	0.00686	0.0146	CcSEcCtD
Rotigotine—Skin exfoliation—Cisplatin—esophageal cancer	0.00655	0.0139	CcSEcCtD
Rotigotine—Fluid retention—Cisplatin—esophageal cancer	0.00651	0.0138	CcSEcCtD
Rotigotine—Contusion—Capecitabine—esophageal cancer	0.00579	0.0123	CcSEcCtD
Rotigotine—Nasal congestion—Cisplatin—esophageal cancer	0.00546	0.0116	CcSEcCtD
Rotigotine—Inflammation—Capecitabine—esophageal cancer	0.00521	0.0111	CcSEcCtD
Rotigotine—Hiccups—Capecitabine—esophageal cancer	0.00505	0.0107	CcSEcCtD
Rotigotine—Skin exfoliation—Capecitabine—esophageal cancer	0.00483	0.0102	CcSEcCtD
Rotigotine—Fluid retention—Capecitabine—esophageal cancer	0.0048	0.0102	CcSEcCtD
Rotigotine—Irritability—Cisplatin—esophageal cancer	0.00475	0.0101	CcSEcCtD
Rotigotine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00455	0.00965	CcSEcCtD
Rotigotine—Breast disorder—Cisplatin—esophageal cancer	0.0045	0.00955	CcSEcCtD
Rotigotine—Nasopharyngitis—Cisplatin—esophageal cancer	0.00445	0.00945	CcSEcCtD
Rotigotine—Abnormal vision—Capecitabine—esophageal cancer	0.00441	0.00936	CcSEcCtD
Rotigotine—Sleep disorder—Capecitabine—esophageal cancer	0.00424	0.009	CcSEcCtD
Rotigotine—Sweating increased—Cisplatin—esophageal cancer	0.00419	0.0089	CcSEcCtD
Rotigotine—Swelling—Capecitabine—esophageal cancer	0.00416	0.00883	CcSEcCtD
Rotigotine—Hot flush—Capecitabine—esophageal cancer	0.00392	0.00833	CcSEcCtD
Rotigotine—Menopausal symptoms—Capecitabine—esophageal cancer	0.00389	0.00826	CcSEcCtD
Rotigotine—Inflammation—Methotrexate—esophageal cancer	0.00388	0.00824	CcSEcCtD
Rotigotine—Lethargy—Capecitabine—esophageal cancer	0.00374	0.00795	CcSEcCtD
Rotigotine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00364	0.00773	CcSEcCtD
Rotigotine—Skin exfoliation—Methotrexate—esophageal cancer	0.00359	0.00763	CcSEcCtD
Rotigotine—Irritability—Capecitabine—esophageal cancer	0.0035	0.00744	CcSEcCtD
Rotigotine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00338	0.00718	CcSEcCtD
Rotigotine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00335	0.00712	CcSEcCtD
Rotigotine—Visual impairment—Cisplatin—esophageal cancer	0.00332	0.00705	CcSEcCtD
Rotigotine—Breast disorder—Capecitabine—esophageal cancer	0.00332	0.00704	CcSEcCtD
Rotigotine—Nasopharyngitis—Capecitabine—esophageal cancer	0.00328	0.00697	CcSEcCtD
Rotigotine—Tinnitus—Cisplatin—esophageal cancer	0.00321	0.00682	CcSEcCtD
Rotigotine—Immune system disorder—Cisplatin—esophageal cancer	0.00311	0.0066	CcSEcCtD
Rotigotine—Mediastinal disorder—Cisplatin—esophageal cancer	0.0031	0.00659	CcSEcCtD
Rotigotine—Sweating increased—Capecitabine—esophageal cancer	0.00309	0.00656	CcSEcCtD
Rotigotine—Erythema—Cisplatin—esophageal cancer	0.003	0.00636	CcSEcCtD
Rotigotine—Malnutrition—Cisplatin—esophageal cancer	0.003	0.00636	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00295	0.00626	CcSEcCtD
Rotigotine—Weight increased—Capecitabine—esophageal cancer	0.00289	0.00613	CcSEcCtD
Rotigotine—Muscle spasms—Cisplatin—esophageal cancer	0.00288	0.00612	CcSEcCtD
Rotigotine—Weight decreased—Capecitabine—esophageal cancer	0.00287	0.00609	CcSEcCtD
Rotigotine—Infestation NOS—Capecitabine—esophageal cancer	0.00283	0.006	CcSEcCtD
Rotigotine—Infestation—Capecitabine—esophageal cancer	0.00283	0.006	CcSEcCtD
Rotigotine—Depression—Capecitabine—esophageal cancer	0.00282	0.00599	CcSEcCtD
Rotigotine—Tremor—Cisplatin—esophageal cancer	0.00281	0.00596	CcSEcCtD
Rotigotine—Lethargy—Methotrexate—esophageal cancer	0.00279	0.00592	CcSEcCtD
Rotigotine—Ill-defined disorder—Cisplatin—esophageal cancer	0.00278	0.00591	CcSEcCtD
Rotigotine—Malaise—Cisplatin—esophageal cancer	0.0027	0.00574	CcSEcCtD
Rotigotine—Irritability—Methotrexate—esophageal cancer	0.00261	0.00554	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00253	0.00538	CcSEcCtD
Rotigotine—Discomfort—Cisplatin—esophageal cancer	0.00252	0.00535	CcSEcCtD
Rotigotine—Oedema peripheral—Capecitabine—esophageal cancer	0.0025	0.00531	CcSEcCtD
Rotigotine—Connective tissue disorder—Capecitabine—esophageal cancer	0.00249	0.0053	CcSEcCtD
Rotigotine—Breast disorder—Methotrexate—esophageal cancer	0.00247	0.00524	CcSEcCtD
Rotigotine—Visual impairment—Capecitabine—esophageal cancer	0.00245	0.00519	CcSEcCtD
Rotigotine—Infection—Cisplatin—esophageal cancer	0.00243	0.00516	CcSEcCtD
Rotigotine—Nervous system disorder—Cisplatin—esophageal cancer	0.0024	0.00509	CcSEcCtD
Rotigotine—Skin disorder—Cisplatin—esophageal cancer	0.00238	0.00505	CcSEcCtD
Rotigotine—Tinnitus—Capecitabine—esophageal cancer	0.00237	0.00502	CcSEcCtD
Rotigotine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00236	0.00502	CcSEcCtD
Rotigotine—Anorexia—Cisplatin—esophageal cancer	0.00233	0.00495	CcSEcCtD
Rotigotine—Angiopathy—Capecitabine—esophageal cancer	0.0023	0.00489	CcSEcCtD
Rotigotine—Immune system disorder—Capecitabine—esophageal cancer	0.00229	0.00487	CcSEcCtD
Rotigotine—Mediastinal disorder—Capecitabine—esophageal cancer	0.00229	0.00486	CcSEcCtD
Rotigotine—Hypotension—Cisplatin—esophageal cancer	0.00229	0.00485	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00223	0.00473	CcSEcCtD
Rotigotine—Mental disorder—Capecitabine—esophageal cancer	0.00222	0.00472	CcSEcCtD
Rotigotine—Malnutrition—Capecitabine—esophageal cancer	0.00221	0.00469	CcSEcCtD
Rotigotine—Erythema—Capecitabine—esophageal cancer	0.00221	0.00469	CcSEcCtD
Rotigotine—Paraesthesia—Cisplatin—esophageal cancer	0.0022	0.00466	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00219	0.00466	CcSEcCtD
Rotigotine—Erectile dysfunction—Methotrexate—esophageal cancer	0.00217	0.00462	CcSEcCtD
Rotigotine—Decreased appetite—Cisplatin—esophageal cancer	0.00213	0.00452	CcSEcCtD
Rotigotine—Muscle spasms—Capecitabine—esophageal cancer	0.00212	0.00451	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00211	0.00448	CcSEcCtD
Rotigotine—Infestation NOS—Methotrexate—esophageal cancer	0.0021	0.00447	CcSEcCtD
Rotigotine—Infestation—Methotrexate—esophageal cancer	0.0021	0.00447	CcSEcCtD
Rotigotine—Depression—Methotrexate—esophageal cancer	0.0021	0.00446	CcSEcCtD
Rotigotine—Pain—Cisplatin—esophageal cancer	0.00209	0.00444	CcSEcCtD
Rotigotine—Tremor—Capecitabine—esophageal cancer	0.00207	0.0044	CcSEcCtD
Rotigotine—Ill-defined disorder—Capecitabine—esophageal cancer	0.00205	0.00435	CcSEcCtD
Rotigotine—Feeling abnormal—Cisplatin—esophageal cancer	0.00202	0.00428	CcSEcCtD
Rotigotine—Malaise—Capecitabine—esophageal cancer	0.00199	0.00423	CcSEcCtD
Rotigotine—Vertigo—Capecitabine—esophageal cancer	0.00198	0.00422	CcSEcCtD
Rotigotine—Syncope—Capecitabine—esophageal cancer	0.00198	0.00421	CcSEcCtD
Rotigotine—Loss of consciousness—Capecitabine—esophageal cancer	0.00194	0.00412	CcSEcCtD
Rotigotine—Cough—Capecitabine—esophageal cancer	0.00193	0.00409	CcSEcCtD
Rotigotine—Hypertension—Capecitabine—esophageal cancer	0.00191	0.00405	CcSEcCtD
Rotigotine—Arthralgia—Capecitabine—esophageal cancer	0.00188	0.00399	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00187	0.00397	CcSEcCtD
Rotigotine—Discomfort—Capecitabine—esophageal cancer	0.00186	0.00395	CcSEcCtD
Rotigotine—Dry mouth—Capecitabine—esophageal cancer	0.00184	0.00391	CcSEcCtD
Rotigotine—Visual impairment—Methotrexate—esophageal cancer	0.00182	0.00387	CcSEcCtD
Rotigotine—Confusional state—Capecitabine—esophageal cancer	0.00182	0.00386	CcSEcCtD
Rotigotine—Hypersensitivity—Cisplatin—esophageal cancer	0.0018	0.00383	CcSEcCtD
Rotigotine—Infection—Capecitabine—esophageal cancer	0.00179	0.0038	CcSEcCtD
Rotigotine—Shock—Capecitabine—esophageal cancer	0.00177	0.00377	CcSEcCtD
Rotigotine—Nervous system disorder—Capecitabine—esophageal cancer	0.00177	0.00375	CcSEcCtD
Rotigotine—Tinnitus—Methotrexate—esophageal cancer	0.00176	0.00374	CcSEcCtD
Rotigotine—Asthenia—Cisplatin—esophageal cancer	0.00176	0.00373	CcSEcCtD
Rotigotine—Skin disorder—Capecitabine—esophageal cancer	0.00175	0.00372	CcSEcCtD
Rotigotine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00174	0.0037	CcSEcCtD
Rotigotine—Anorexia—Capecitabine—esophageal cancer	0.00172	0.00365	CcSEcCtD
Rotigotine—Angiopathy—Methotrexate—esophageal cancer	0.00171	0.00364	CcSEcCtD
Rotigotine—Immune system disorder—Methotrexate—esophageal cancer	0.00171	0.00362	CcSEcCtD
Rotigotine—Mediastinal disorder—Methotrexate—esophageal cancer	0.0017	0.00362	CcSEcCtD
Rotigotine—Hypotension—Capecitabine—esophageal cancer	0.00168	0.00358	CcSEcCtD
Rotigotine—Diarrhoea—Cisplatin—esophageal cancer	0.00167	0.00355	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—esophageal cancer	0.00166	0.00351	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—esophageal cancer	0.00164	0.00349	CcSEcCtD
Rotigotine—Erythema—Methotrexate—esophageal cancer	0.00164	0.00349	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00164	0.00349	CcSEcCtD
Rotigotine—Insomnia—Capecitabine—esophageal cancer	0.00163	0.00346	CcSEcCtD
Rotigotine—Paraesthesia—Capecitabine—esophageal cancer	0.00162	0.00344	CcSEcCtD
Rotigotine—Dyspepsia—Capecitabine—esophageal cancer	0.00159	0.00337	CcSEcCtD
Rotigotine—Decreased appetite—Capecitabine—esophageal cancer	0.00157	0.00333	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00156	0.00331	CcSEcCtD
Rotigotine—Vomiting—Cisplatin—esophageal cancer	0.00156	0.0033	CcSEcCtD
Rotigotine—Fatigue—Capecitabine—esophageal cancer	0.00155	0.0033	CcSEcCtD
Rotigotine—Rash—Cisplatin—esophageal cancer	0.00154	0.00328	CcSEcCtD
Rotigotine—Constipation—Capecitabine—esophageal cancer	0.00154	0.00327	CcSEcCtD
Rotigotine—Pain—Capecitabine—esophageal cancer	0.00154	0.00327	CcSEcCtD
Rotigotine—Dermatitis—Cisplatin—esophageal cancer	0.00154	0.00327	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—esophageal cancer	0.00153	0.00324	CcSEcCtD
Rotigotine—Feeling abnormal—Capecitabine—esophageal cancer	0.00149	0.00316	CcSEcCtD
Rotigotine—Malaise—Methotrexate—esophageal cancer	0.00148	0.00315	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—esophageal cancer	0.00148	0.00314	CcSEcCtD
Rotigotine—Nausea—Cisplatin—esophageal cancer	0.00145	0.00309	CcSEcCtD
Rotigotine—Cough—Methotrexate—esophageal cancer	0.00144	0.00305	CcSEcCtD
Rotigotine—Urticaria—Capecitabine—esophageal cancer	0.00143	0.00304	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—esophageal cancer	0.0014	0.00297	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00139	0.00295	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—esophageal cancer	0.00138	0.00294	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—esophageal cancer	0.00135	0.00287	CcSEcCtD
Rotigotine—Infection—Methotrexate—esophageal cancer	0.00133	0.00283	CcSEcCtD
Rotigotine—Hypersensitivity—Capecitabine—esophageal cancer	0.00133	0.00282	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—esophageal cancer	0.00132	0.0028	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—esophageal cancer	0.0013	0.00277	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—esophageal cancer	0.0013	0.00276	CcSEcCtD
Rotigotine—Asthenia—Capecitabine—esophageal cancer	0.00129	0.00275	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—esophageal cancer	0.00128	0.00272	CcSEcCtD
Rotigotine—Pruritus—Capecitabine—esophageal cancer	0.00128	0.00271	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—esophageal cancer	0.00125	0.00266	CcSEcCtD
Rotigotine—Diarrhoea—Capecitabine—esophageal cancer	0.00123	0.00262	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00122	0.0026	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—esophageal cancer	0.00121	0.00258	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—esophageal cancer	0.00121	0.00256	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—esophageal cancer	0.00119	0.00253	CcSEcCtD
Rotigotine—Dizziness—Capecitabine—esophageal cancer	0.00119	0.00253	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—esophageal cancer	0.00118	0.00251	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—esophageal cancer	0.00117	0.00248	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00116	0.00246	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—esophageal cancer	0.00116	0.00246	CcSEcCtD
Rotigotine—Pain—Methotrexate—esophageal cancer	0.00115	0.00244	CcSEcCtD
Rotigotine—Vomiting—Capecitabine—esophageal cancer	0.00115	0.00243	CcSEcCtD
Rotigotine—Rash—Capecitabine—esophageal cancer	0.00114	0.00241	CcSEcCtD
Rotigotine—Dermatitis—Capecitabine—esophageal cancer	0.00114	0.00241	CcSEcCtD
Rotigotine—Headache—Capecitabine—esophageal cancer	0.00113	0.0024	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—esophageal cancer	0.00111	0.00235	CcSEcCtD
Rotigotine—Nausea—Capecitabine—esophageal cancer	0.00107	0.00227	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—esophageal cancer	0.00107	0.00226	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—esophageal cancer	0.000989	0.0021	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—esophageal cancer	0.000963	0.00205	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—esophageal cancer	0.00095	0.00202	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—esophageal cancer	0.000918	0.00195	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—esophageal cancer	0.000888	0.00188	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—esophageal cancer	0.000853	0.00181	CcSEcCtD
Rotigotine—Rash—Methotrexate—esophageal cancer	0.000846	0.0018	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—esophageal cancer	0.000846	0.0018	CcSEcCtD
Rotigotine—Headache—Methotrexate—esophageal cancer	0.000841	0.00179	CcSEcCtD
Rotigotine—Nausea—Methotrexate—esophageal cancer	0.000797	0.00169	CcSEcCtD
Rotigotine—ADRA2B—Signaling Pathways—PSME1—esophageal cancer	0.000162	0.000306	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PSME2—esophageal cancer	0.000162	0.000306	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ANXA1—esophageal cancer	0.000161	0.000305	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CA2—esophageal cancer	0.000161	0.000304	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.00016	0.000302	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.00016	0.000302	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HIF1A—esophageal cancer	0.000159	0.000301	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000157	0.000297	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SST—esophageal cancer	0.000157	0.000296	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PSME2—esophageal cancer	0.000156	0.000296	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PSME1—esophageal cancer	0.000156	0.000296	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—XIAP—esophageal cancer	0.000156	0.000296	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ANXA1—esophageal cancer	0.000156	0.000294	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000155	0.000293	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—EP300—esophageal cancer	0.000155	0.000292	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NOTCH2—esophageal cancer	0.000154	0.000291	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—GHRL—esophageal cancer	0.000153	0.000289	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOTCH3—esophageal cancer	0.000153	0.000289	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—KDR—esophageal cancer	0.000152	0.000288	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NOTCH2—esophageal cancer	0.000152	0.000287	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFBR2—esophageal cancer	0.000152	0.000287	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SST—esophageal cancer	0.000151	0.000286	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—FBXW7—esophageal cancer	0.00015	0.000284	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.00015	0.000283	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ADH7—esophageal cancer	0.00015	0.000283	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000148	0.00028	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CTNNA1—esophageal cancer	0.000148	0.000279	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000148	0.000279	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000148	0.000279	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—GHRL—esophageal cancer	0.000148	0.000279	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL2—esophageal cancer	0.000147	0.000278	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—FBXW7—esophageal cancer	0.000145	0.000274	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000144	0.000272	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SMAD4—esophageal cancer	0.000144	0.000271	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NOTCH1—esophageal cancer	0.000143	0.000271	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.00014	0.000265	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PSME2—esophageal cancer	0.000137	0.00026	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PSME1—esophageal cancer	0.000137	0.00026	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOTCH2—esophageal cancer	0.000137	0.000259	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ANXA1—esophageal cancer	0.000137	0.000258	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFBR2—esophageal cancer	0.000137	0.000258	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000136	0.000257	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CA1—esophageal cancer	0.000136	0.000257	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFBR2—esophageal cancer	0.000135	0.000255	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000134	0.000253	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000134	0.000253	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SST—esophageal cancer	0.000133	0.000251	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000132	0.00025	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ADH1B—esophageal cancer	0.000131	0.000248	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CREBBP—esophageal cancer	0.00013	0.000246	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOTCH3—esophageal cancer	0.00013	0.000245	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—GHRL—esophageal cancer	0.00013	0.000245	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SMAD4—esophageal cancer	0.000129	0.000244	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000128	0.000242	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—EGFR—esophageal cancer	0.000128	0.000241	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SMAD4—esophageal cancer	0.000128	0.000241	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—FBXW7—esophageal cancer	0.000127	0.000241	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TYMP—esophageal cancer	0.000125	0.000237	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CA2—esophageal cancer	0.000124	0.000235	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000123	0.000233	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000122	0.000231	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000122	0.000231	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	0.000122	0.00023	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000122	0.00023	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALOX15—esophageal cancer	0.000119	0.000225	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HIF1A—esophageal cancer	0.000117	0.000222	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFBR2—esophageal cancer	0.000117	0.000222	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000116	0.00022	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NOS3—esophageal cancer	0.000116	0.00022	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOTCH2—esophageal cancer	0.000116	0.00022	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000115	0.000218	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000115	0.000218	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	0.000115	0.000218	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	0.000114	0.000216	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTO1—esophageal cancer	0.000113	0.000214	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TPI1—esophageal cancer	0.000113	0.000214	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KDR—esophageal cancer	0.000112	0.000212	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SMAD4—esophageal cancer	0.000111	0.00021	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—PIK3CA—esophageal cancer	0.000111	0.00021	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TP53—esophageal cancer	0.000111	0.000209	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000109	0.000206	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—ERBB2—esophageal cancer	0.000109	0.000206	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALDOB—esophageal cancer	0.000109	0.000205	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NOTCH1—esophageal cancer	0.000106	0.0002	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HIF1A—esophageal cancer	0.000106	0.0002	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GAPDH—esophageal cancer	0.000105	0.000198	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HIF1A—esophageal cancer	0.000104	0.000197	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000104	0.000196	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CRABP1—esophageal cancer	0.000104	0.000196	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFBR2—esophageal cancer	0.000103	0.000195	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000103	0.000194	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000101	0.000191	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KDR—esophageal cancer	0.000101	0.000191	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KDR—esophageal cancer	9.98e-05	0.000189	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GNG7—esophageal cancer	9.86e-05	0.000186	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SMAD4—esophageal cancer	9.76e-05	0.000184	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ENO1—esophageal cancer	9.72e-05	0.000184	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS1—esophageal cancer	9.72e-05	0.000184	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TYMP—esophageal cancer	9.67e-05	0.000183	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CCND1—esophageal cancer	9.62e-05	0.000182	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CREBBP—esophageal cancer	9.59e-05	0.000181	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PSME2—esophageal cancer	9.58e-05	0.000181	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PSME1—esophageal cancer	9.58e-05	0.000181	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NOTCH1—esophageal cancer	9.53e-05	0.00018	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—EGFR—esophageal cancer	9.43e-05	0.000178	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	9.42e-05	0.000178	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	9.41e-05	0.000178	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NOTCH1—esophageal cancer	9.4e-05	0.000178	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CDKN1A—esophageal cancer	9.3e-05	0.000176	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALDH2—esophageal cancer	9.24e-05	0.000175	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.17e-05	0.000173	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HIF1A—esophageal cancer	9.09e-05	0.000172	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—PIK3CA—esophageal cancer	9.01e-05	0.00017	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KDR—esophageal cancer	9.01e-05	0.00017	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EP300—esophageal cancer	8.85e-05	0.000167	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTT1—esophageal cancer	8.79e-05	0.000166	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTO1—esophageal cancer	8.75e-05	0.000165	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TPI1—esophageal cancer	8.75e-05	0.000165	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KDR—esophageal cancer	8.7e-05	0.000164	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	8.69e-05	0.000164	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.65e-05	0.000164	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CREBBP—esophageal cancer	8.64e-05	0.000163	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NOS3—esophageal cancer	8.59e-05	0.000162	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CREBBP—esophageal cancer	8.52e-05	0.000161	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—EGFR—esophageal cancer	8.49e-05	0.00016	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	8.49e-05	0.00016	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.39e-05	0.000159	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—EGFR—esophageal cancer	8.37e-05	0.000158	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	8.27e-05	0.000156	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ENO1—esophageal cancer	8.24e-05	0.000156	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS1—esophageal cancer	8.24e-05	0.000156	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOTCH1—esophageal cancer	8.19e-05	0.000155	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—PIK3CA—esophageal cancer	8.18e-05	0.000155	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PSME2—esophageal cancer	8.11e-05	0.000153	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PSME1—esophageal cancer	8.11e-05	0.000153	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	8.11e-05	0.000153	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.07e-05	0.000153	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—ERBB2—esophageal cancer	8.03e-05	0.000152	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—PIK3CA—esophageal cancer	8e-05	0.000151	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CRABP1—esophageal cancer	8e-05	0.000151	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HIF1A—esophageal cancer	7.98e-05	0.000151	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	7.77e-05	0.000147	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NOS3—esophageal cancer	7.73e-05	0.000146	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MYC—esophageal cancer	7.71e-05	0.000146	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	7.69e-05	0.000145	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KDR—esophageal cancer	7.64e-05	0.000144	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NOS3—esophageal cancer	7.63e-05	0.000144	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GNG7—esophageal cancer	7.61e-05	0.000144	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	7.56e-05	0.000143	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EGFR—esophageal cancer	7.55e-05	0.000143	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CREBBP—esophageal cancer	7.43e-05	0.00014	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—PIK3CA—esophageal cancer	7.37e-05	0.000139	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—EGFR—esophageal cancer	7.3e-05	0.000138	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—PIK3CA—esophageal cancer	7.27e-05	0.000137	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—ERBB2—esophageal cancer	7.23e-05	0.000137	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	7.23e-05	0.000137	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOTCH1—esophageal cancer	7.19e-05	0.000136	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—ERBB2—esophageal cancer	7.14e-05	0.000135	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.13e-05	0.000135	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCND1—esophageal cancer	7.1e-05	0.000134	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—HMOX1—esophageal cancer	7.09e-05	0.000134	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.09e-05	0.000134	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	7e-05	0.000132	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	6.98e-05	0.000132	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	6.89e-05	0.00013	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CDKN1A—esophageal cancer	6.87e-05	0.00013	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ABCB1—esophageal cancer	6.81e-05	0.000129	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTT1—esophageal cancer	6.78e-05	0.000128	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	6.7e-05	0.000127	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOS3—esophageal cancer	6.65e-05	0.000126	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	6.58e-05	0.000124	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	6.56e-05	0.000124	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PIK3CA—esophageal cancer	6.55e-05	0.000124	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EP300—esophageal cancer	6.53e-05	0.000124	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CREBBP—esophageal cancer	6.52e-05	0.000123	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	6.44e-05	0.000122	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—esophageal cancer	6.41e-05	0.000121	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—esophageal cancer	6.39e-05	0.000121	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.36e-05	0.00012	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ENO1—esophageal cancer	6.36e-05	0.00012	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—esophageal cancer	6.34e-05	0.00012	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	6.33e-05	0.00012	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—esophageal cancer	6.31e-05	0.000119	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PSME2—esophageal cancer	6.26e-05	0.000118	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PSME1—esophageal cancer	6.26e-05	0.000118	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	6.22e-05	0.000118	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1A—esophageal cancer	6.18e-05	0.000117	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	6.12e-05	0.000116	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1A—esophageal cancer	6.1e-05	0.000115	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HMOX1—esophageal cancer	6.01e-05	0.000114	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.89e-05	0.000111	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EP300—esophageal cancer	5.88e-05	0.000111	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOS3—esophageal cancer	5.84e-05	0.00011	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EP300—esophageal cancer	5.8e-05	0.00011	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ABCB1—esophageal cancer	5.77e-05	0.000109	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—esophageal cancer	5.69e-05	0.000108	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	5.69e-05	0.000108	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—esophageal cancer	5.57e-05	0.000105	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	5.56e-05	0.000105	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	5.51e-05	0.000104	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—esophageal cancer	5.5e-05	0.000104	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ERBB2—esophageal cancer	5.46e-05	0.000103	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.4e-05	0.000102	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	5.32e-05	0.0001	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EP300—esophageal cancer	5.24e-05	9.9e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—esophageal cancer	5.13e-05	9.69e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.08e-05	9.6e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EP300—esophageal cancer	5.06e-05	9.56e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—esophageal cancer	5.06e-05	9.56e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—esophageal cancer	5.01e-05	9.48e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—esophageal cancer	4.95e-05	9.35e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CA—esophageal cancer	4.83e-05	9.14e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—esophageal cancer	4.82e-05	9.12e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—esophageal cancer	4.68e-05	8.84e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	4.67e-05	8.82e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.64e-05	8.76e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—esophageal cancer	4.57e-05	8.63e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CREBBP—esophageal cancer	4.55e-05	8.6e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	4.47e-05	8.44e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.45e-05	8.41e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EP300—esophageal cancer	4.44e-05	8.39e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—esophageal cancer	4.41e-05	8.33e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.36e-05	8.24e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CA—esophageal cancer	4.35e-05	8.22e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—esophageal cancer	4.31e-05	8.15e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CA—esophageal cancer	4.29e-05	8.12e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—esophageal cancer	4.21e-05	7.96e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—esophageal cancer	4.15e-05	7.85e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NOS3—esophageal cancer	4.07e-05	7.7e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	3.88e-05	7.33e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—esophageal cancer	3.87e-05	7.31e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CREBBP—esophageal cancer	3.85e-05	7.28e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—esophageal cancer	3.79e-05	7.15e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—esophageal cancer	3.75e-05	7.09e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	3.74e-05	7.07e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—esophageal cancer	3.73e-05	7.04e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—esophageal cancer	3.62e-05	6.84e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NOS3—esophageal cancer	3.45e-05	6.52e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	3.29e-05	6.21e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—esophageal cancer	3.18e-05	6.01e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.16e-05	5.96e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—EP300—esophageal cancer	3.1e-05	5.86e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.97e-05	5.62e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NOS3—esophageal cancer	2.66e-05	5.03e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—EP300—esophageal cancer	2.62e-05	4.96e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.44e-05	4.6e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.29e-05	4.33e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—EP300—esophageal cancer	2.03e-05	3.83e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.94e-05	3.67e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.5e-05	2.83e-05	CbGpPWpGaD
